United States · Platforms & data · Yahoo Finance

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory ...

Published by Yahoo Finance · United States 10 h ago

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

MarketBeat

What Torm (TRMD) Said on Its Q3 Earnings Call

The Motley Fool

Omega Healthcare (OHI) Q3 2026 Earnings Call Transcript

MarketWatch

Microsoft and Amazon combine for a $400 billion market-cap boost — and these factors show why

Investing.com

Payoneer Global Inc stock hits 52-week high at 7.2 USD

CNBC

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Benzinga